Risk factor
Low price volatility
Profitability factor
Overvalued vs peers
About
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expensive' on E
Target Price
The average target price of SDZ.SW is 60 and suggests 17% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to dec
Buy
Sell